{"id":"apd-209-eye-drops","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Eye irritation"}]},"_chembl":{"chemblId":"CHEMBL458895","moleculeType":"Small molecule","molecularWeight":"237.22"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The exact mechanism of action of APD-209 Eye drops involves the inhibition of a particular enzyme that plays a key role in the inflammatory process. This inhibition leads to a reduction in the production of pro-inflammatory mediators, resulting in decreased inflammation in the eye. Further research is needed to fully understand the mechanism of action of APD-209 Eye drops.","oneSentence":"APD-209 Eye drops are designed to reduce inflammation in the eye by inhibiting the action of a specific enzyme.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T02:28:43.401Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of dry eye disease"}]},"trialDetails":[{"nctId":"NCT01977443","phase":"PHASE2","title":"Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC)","status":"COMPLETED","sponsor":"Adenovir Pharma AB","startDate":"2013-11","conditions":"Viral Conjunctivitis","enrollment":47}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":8827,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"APD-209 Eye drops","genericName":"APD-209 Eye drops","companyName":"Adenovir Pharma AB","companyId":"adenovir-pharma-ab","modality":"Small molecule","firstApprovalDate":"","aiSummary":"APD-209 Eye drops are being studied for the treatment of Viral Conjunctivitis. The therapeutic efficacy of APD-209 Eye drops is being evaluated in the treatment of Epidemic Keratoconjunctivitis (EKC), a condition that is likely related to Viral Conjunctivitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}